Skip to main content
. 2019 Aug 2;9:717. doi: 10.3389/fonc.2019.00717

Table 2.

Cytotoxicity of oxaliplatin, mAb (anti-c-Met IgG), and ADC (anti-c-Met IgG-OXA) to the HepG2 and shMet-HepG2 cell lines.

IC50 (μmol) Oxaliplatin Anti-c-Met IgG Anti-c-Met IgG-OXA
HepG2 44.96 ± 1.05 >1,000 10.34 ± 0.84
ShMet-HepG2 33.10 ± 1.92 >1,000 >1,000